FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...